Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,144 | -48,411 | -21,529 | -89,298 | -70,513 |
| Depreciation Amortization | 846 | 560 | 283 | 1,245 | 941 |
| Accounts payable and accrued liabilities | 1,973 | 3,921 | 923 | -2,920 | -1,416 |
| Other Working Capital | 1,701 | -2,330 | -4,556 | -12,467 | -9,866 |
| Other Operating Activity | 10,256 | 4,058 | 2,859 | 22,215 | 17,937 |
| Operating Cash Flow | $-66,368 | $-42,202 | $-22,020 | $-81,225 | $-62,917 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -488 | -380 | -378 | -374 | -376 |
| Other Investing Activity | 131 | 71 | 7 | 11 | 0 |
| Investing Cash Flow | $-357 | $-309 | $-371 | $-363 | $-376 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49,853 | N/A | N/A | N/A | N/A |
| Debt Repayment | -40,612 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 216,072 | 216,245 | 75 | 76,869 | 77,269 |
| Other Financing Activity | -280 | -9 | -127 | -185 | -228 |
| Financing Cash Flow | $225,033 | $216,236 | $-52 | $76,684 | $77,041 |
| Beginning Cash Position | 141,636 | 141,636 | 141,636 | 146,540 | 146,540 |
| End Cash Position | 299,944 | 315,361 | 119,193 | 141,636 | 160,288 |
| Net Cash Flow | $158,308 | $173,725 | $-22,443 | $-4,904 | $13,748 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,368 | -42,202 | -22,020 | -81,225 | -62,917 |
| Capital Expenditure | -488 | -380 | -378 | -374 | -376 |
| Free Cash Flow | -66,856 | -42,582 | -22,398 | -81,599 | -63,293 |